As antibody-drug conjugates aspire to advance to earlier-line treatments, harnessing innovation has never been more important to redefine the oncology standard of care and provide long-term benefit to ...
SAN DIEGO, March 24, 2026 (GLOBE NEWSWIRE)-- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”), a provider of next-generation New Approach Methodologies (NAMs) for preclinical safety, ...
With three dynamic tracks covering discovery, preclinical, clinical, and CMC, plus exclusive seminar days on ADC fundamentals and Bispecific ADCs, this guide ensures you gain critical insights and ...
ADCs are a major new market; Company demonstrates ability to discern antibody toxicity from payload toxicity and show differential linker chemistry toxicity SAN DIEGO, March 24, 2026 (GLOBE NEWSWIRE)- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results